Company Monitoring Page for Incyte

latest headlines for company on cafepharma

Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
Tags:
drug launches, Dendreon, Incyte, Human Genome Sciences, Regeneron, Seattle Genetics, Vertex
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals
Is YM the Next Incyte?
Minyanville
Mon, 12/19/11 - 02:19 pm
Tags:
Incyte, YM BioSciences, CYT387, myelofibrosis
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Fri, 12/9/11 - 11:11 am
Tags:
Seattle Genetics, ONYX Pharmaceuticals, Incyte, Celgene, Ariad Pharmaceuticals
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Tags:
Biomarin, BioSpecifics Technologies, Complete Genomics, Incyte, Medivation, Insmed, Momenta, Questcor, Seattle Genetics, Sangamo BioSciences, XenoPort
Incyte: Where Do We Go From Here?
Seeking Alpha
Sat, 11/19/11 - 12:15 pm
Tags:
Incyte
Incyte CEO Touts Prospects of New Cancer Drug
Minyanville
Sat, 11/19/11 - 11:38 am
Tags:
Jakafi, Incyte, myelofibrosis
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
Thu, 11/17/11 - 09:09 am
Tags:
FDA, myelofibrosis, bone marrow disorder, Jakafi, JAK inhibitors, Incyte
6 Biotech Stocks Analysts Expect To Double In 2012
Seeking Alpha
Wed, 11/2/11 - 11:53 am
Tags:
Sequenom, Incyte, Novavax, Zalicus, YM BioSciences, Alimera
9 Biotech Stocks Trading At Steepest Discount To Target Price
Seeking Alpha
Sun, 10/30/11 - 12:40 pm
Tags:
Inhibitex, Affymax, Alnylam, Incyte, Ziopharm, Array Biopharma, Ariad Pharmaceuticals, Xoma, Complete Genomics
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Fri, 10/28/11 - 11:07 am
Tags:
Celgene, Pacira, Incyte, BioSante, Regeneron, Transcept, Antares
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Tags:
Bristol-Myers Squibb, Dapagliflozin, BioSante, Bio-T-Gel, Regeneron, Eylea, Transcept, Intermezzo, Incyte, ruxolitinib, Antares, Anturol
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Gilead, Human Genome Sciences, Incyte, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Theravance
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Seeking Alpha
Sun, 09/25/11 - 12:55 pm
Tags:
Amyris, NPS Pharmaceuticals, Targacept, Sequenom, Cadence Pharmaceuticals, Enzon, Dendreon, Incyte
The Big Bet on YM BioSciences
Motley Fool
Thu, 09/1/11 - 12:11 pm
Tags:
YM BioSciences, myelofibrosis, ruxolitinib, CYT387, Novartis, Incyte
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
Tags:
biotech, drug approvals, FDA, Eyelea, Regeneron, Dendreon, Provenge, NuPathe, Zelrix, Adcetris, Seattle Genetics, Soliris, Alexion, Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, EXPAREL, Pacira, Roche, Zelboraf, Iluvien, Alimera, Bio-T-Gel, Teva Pharmaceuticals, BioSante, Zevalin, Spectrum, ruxolitinib, Incyte, Novartis, Pfizer, crizotinib, Antares, Anturol, Bydureon, Amlyin, Eli Lilly, Alkermes, AZ-004, Alexza, Corlux, Corcept Therapeutics, Affymax, Takeda, peginesatide, Levadex, MAP Pharmaceuticals
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Tags:
Targacept, Aveo Pharmaceutical, Threshold Pharmaceuticals, Raptor Pharmaceuticals, Vertex Pharmaceuticals, Soligenix, Spectrum Pharmaceuticals, NuPathe, Pharmasset, Incyte, Adventrx, Celsion, Alimera, GTx, Ariad Pharmaceuticals
7 Rallying Biotech Stocks With Conservative Accounting Practices
Seeking Alpha
Fri, 07/1/11 - 09:56 am
Tags:
Acorda Therapeutics, Incyte, Chelsea Therapeutics, Regeneron, Spectrum Pharmaceuticals, Jazz Pharmaceuticals, Neurocrine
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
Tags:
FDA, Bristol-Myers Squibb, AstraZeneca, Pfizer, Incyte, Novartis, ruxolitinib, Apixaban, Dapagliflozin
Risk-Reward Balanced at Incyte
Yahoo/Zacks.com
Wed, 06/15/11 - 09:26 pm
Tags:
Incyte, Eli Lilly, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.